GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDenta Corp (OTCPK:IDTA) » Definitions » ROCE %

IDTA (IDenta) ROCE % : 26.32% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is IDenta ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IDenta's annualized ROCE % for the quarter that ended in Sep. 2024 was 26.32%.


IDenta ROCE % Historical Data

The historical data trend for IDenta's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDenta ROCE % Chart

IDenta Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial 200.00 149.49 23.84 18.67 3.27

IDenta Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.85 44.89 50.71 20.12 26.32

IDenta ROCE % Calculation

IDenta's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=0.044/( ( (1.624 - 0.243) + (1.529 - 0.219) )/ 2 )
=0.044/( (1.381+1.31)/ 2 )
=0.044/1.3455
=3.27 %

IDenta's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=0.4/( ( (1.663 - 0.195) + (1.774 - 0.202) )/ 2 )
=0.4/( ( 1.468 + 1.572 )/ 2 )
=0.4/1.52
=26.32 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDenta  (OTCPK:IDTA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


IDenta ROCE % Related Terms

Thank you for viewing the detailed overview of IDenta's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDenta Business Description

Traded in Other Exchanges
N/A
Address
Bethlehem Road 120, Jerusalem, ISR, 9342001
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, the military, government agencies, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Precursors of Drugs Test kits, portable sniffers, Bullet-hole testing kits, and others. The Company currently sells its products to law enforcement organizations in the following countries Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The Company also sells to retail markets in the United States, Italy, and South Africa.